glp 1 and the brain Dual-action obesity drug rewires circuits for appetite Central GLP-1 contributes to improved

CSF and brain indices of insulin resistance, oxidative stress and neuro-inflammation in early versus late Alzheimers disease

Historical advents of cannabis use The cultivation of Cannabis sativa L

For the liraglutide cohort, 14.5 percent of patients treating obesity lost at least 10 percent of their weight, and 9.3 percent for type 2 diabetes

doi: 10.3389/fendo.2025.1530985 Received 19 November 2024 Accepted 02 January 2025 Published 03 February 2025 Volume 16 - 2025 Edited by Kirk M

Meanwhile, payer programs (e.g

Emerging vectors Despite significant advances, conventional NPs continue to face key limitations, including rapid clearance from the bloodstream, immune recognition, and poor accumulation at target sites [153]